cetrotide ® 025 mg
baxter oncology gmbh, . - cetrorelix (eq. a 0,26 – 0,27 mg de acetato de cetrorelix) - polvo liofilizado para solución inyectable sc. - 0,25 mg
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
genoxal 50 mg comprimidos recubiertos
baxter oncology gmbh - ciclofosfamida - comprimido recubierto - 50 mg - ciclofosfamida 50 mg - ciclofosfamida
miltex solucion
baxter oncology gmbh - miltefosina - soluciÓn cutÁnea - 60 mg/ml - miltefosina 60 mg - miltefosina
bendamustina baxter 2,5 mg/ml polvo para concentrado para solucion para perfusion efg
baxter s.l. - bendamustina hidrocloruro - polvo para concentrado para soluciÓn para perfusiÓn - 100 mg - bendamustina hidrocloruro 100 mg - bendamustina
uromitexan 400 mg inyectable
baxter oncology gmbh [de] germany - cada ampolla de 4 ml contiene: mesna 400.0 mg - solucion inyectable - cada ampolla de 4 ml contiene: mesna 400.0 mg
holoxan 1g polvo para solucion inyectable
baxter oncology gmbh [de] germany - ifosfamida 1000 mg - polvo para soluciÓn inyectable - ifosfamida 1000 mg
mitoxantrone baxter 2 mg/ml solución inyectable
baxter oncology gmbh - solución inyectable - 2 mg/ml
endoxan 1000mg inyectable
laboratorios baxter oncology gmbh [de] germany - ciclofosfamida 1 h20 1069.0 mg (equivalente a ciclofosfamida anhidra 1000 mg) - polvo para reconstituir inyectable - ciclofosfamida 1 h20
endoxan 500mg inyectable
laboratorios baxter oncology gmbh [de] germany - ciclofosfamida anhidra 500 mg - polvo para soluciÓn inyectable - cada frasco ampolla contiene: ciclofosfamida 1h2o (equivalente a ciclofosfamida anhidra 500 mg)